<DOC>
	<DOCNO>NCT00628719</DOCNO>
	<brief_summary>The purpose trial evaluate efficacy single dose amphotericin B treatment Visceral Leishmaniasis ( VL ) India .</brief_summary>
	<brief_title>Single Infusion Liposomal Amphotericin B Indian Visceral Leishmaniasis</brief_title>
	<detailed_description>The purpose trial evaluate efficacy single dose amphotericin B treatment VL India . Primary objective : Comparison efficacy single dose 10 mg/kg liposomal amphotericin B amphotericin B deoxycholate regard final cure rate Secondary objective : . Comparison safety single dose 10 mg/kg liposomal amphotericin B amphotericin B deoxycholate administer propose dosage regimens .</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis , Visceral</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<mesh_term>Amphotericin B , deoxycholate drug combination</mesh_term>
	<mesh_term>Deoxycholic Acid</mesh_term>
	<criteria>Children adults 265 year age ( inclusive ) either gender . Diagnosis VL confirm spleen bone marrow aspirate . Clinical sign symptom compatible VL . Biochemical haematological test value follow : Haemoglobin &gt; 3.5g/100mL White blood cell count &gt; 0.75 x109/L Platelet count &gt; 40 x 109/L AST , ALT alkaline phosphatase &lt; 5 time upper normal limit Prothrombin time &lt; 4 second control Serum creatinine level 1.5 time upper normal limit Serum potassium level within normal limit HIV negative . A history intercurrent concurrent disease ( e.g . chronic alcohol consumption drug addiction ; renal , hepatic , cardiovascular CNS disease ; diabetes ; tuberculosis ; infectious major psychiatric disease ) may introduce variable affect outcome study . Any condition investigator think may prevent patient complete study therapy subsequent followup . Proteinuria ( &gt; 2+ ) . A history allergy hypersensitivity amphotericin B Previous treatment VL within two week enrollment study . Prior treatment failure amphotericin B .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Visceral leishmaniasis</keyword>
	<keyword>India</keyword>
	<keyword>Liposomal Amphotericin B</keyword>
	<keyword>Amphotericin B deoxycholate</keyword>
</DOC>